三重阴性乳腺癌的表观遗传疗法:概念,愿景和挑战
1Institute of Pathology, Hannover Medical School, Carl-Neuberg-Str. 1, D-30625 Hannover, Germany.
Cancers
|June 27, 2024
概括
针对DNA甲基化和基因组修饰的表观遗传药物显示出对治疗侵袭性三阴性乳腺癌的前途. 组合疗法,特别是免疫检查点抑制剂,正成为一种关键的治疗策略.
科学领域:
- 在瘤学瘤学.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 癌症生物学 癌症生物学
背景情况:
- 乳腺癌是一种异质的恶性瘤,具有三阴性乳腺癌 (TNBC),呈现出更具侵略性的病程和有限的治疗选择.
- 癌细胞表现出遗传和表观遗传异常,包括DNA甲基化和基因素修饰.
- 表观遗传修饰是可逆的,这使得它们成为治疗干预的有吸引力的目标.
研究的目的:
- 审查关于乳腺癌表观遗传疗法的当前知识,特别关注三阴性乳腺癌.
- 解释与DNA甲基化和TNBC中的基因组修饰相关的概念.
- 突出需要未来研究和澄清TNBC表观遗传治疗策略的领域.
主要方法:
- 审查关于乳腺癌表观遗传修饰和治疗的现有文献.
- 专注于DNA甲基化和基因素修饰作为关键的表观遗传异常.
- 对当前临床试验和组合治疗方法的分析.
主要成果:
- 针对DNA甲基化和基因组修饰的表观遗传药物为TNBC提供了潜在的新治疗途径.
- 组合疗法,特别是那些将表观遗传药物与免疫检查点抑制剂结合在一起的疗法,显示出有前途的疗效.
- 在TNBC的表观遗传疗法领域存在重大知识缺口和未来研究领域.
结论:
- 表观遗传疗法,特别是针对DNA甲基化和基因素修饰,代表了治疗三阴性乳腺癌的前沿前沿.
- 结合策略,特别是与免疫检查点抑制剂的结合策略,对于提高治疗效率至关重要.
- 进一步的研究是必不可少的,以充分阐明潜力,并优化表观遗传药物在TNBC治疗中的应用.
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:37Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K
02:38Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
01:27Tumor Immunotherapy
510
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
510
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K